Condition: Pulmonary Disease · Postoperative Complications · Sponsor: University of Texas Southwestern Medical Center
The purpose of this prospective randomized clinical trial is to evaluate three different types of hyperinflation respiratory therapies, Intermittent Positive Pressure Breathing (IPPB), Intermittent positive end expiratory pressure (EzPAP), Metaneb. Investigators will examine which hyperinflation therapy provides better lung expansion and may improve lung recovery after surgery.
This description comes directly from the study's public registry record.
Jaffer Odeh, MD · 214-786-1067 · Jaffer.Odeh@UTSouthwestern.edu
Emily Melikman, RN · 214-645-7011 · Emily.Melikman@UTSouthwestern.edu
Always discuss trial participation with your own doctor first.
| UT Southwestern Clements University Hospital | Dallas, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04164173